_version_ 1783703876130570240
author Liu, Jin
Hu, Xiaoxia
Jia, Yanchun
Lu, Jin
Lee, Jae Hoon
Kim, Kihyun
Chen, Wenming
Liu, Aijun
Liu, Yang
Chen, Qi
Zhang, Chunyang
Suh, Cheolwon
Kim, Min Kyoung
Zhou, Fan
Chng, Wee Joo
Kumar, Shaji K.
Durie, Brian
Hou, Jian
Fu, Weijun
Du, Juan
author_facet Liu, Jin
Hu, Xiaoxia
Jia, Yanchun
Lu, Jin
Lee, Jae Hoon
Kim, Kihyun
Chen, Wenming
Liu, Aijun
Liu, Yang
Chen, Qi
Zhang, Chunyang
Suh, Cheolwon
Kim, Min Kyoung
Zhou, Fan
Chng, Wee Joo
Kumar, Shaji K.
Durie, Brian
Hou, Jian
Fu, Weijun
Du, Juan
author_sort Liu, Jin
collection PubMed
description
format Online
Article
Text
id pubmed-8179848
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81798482021-06-17 Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN) Liu, Jin Hu, Xiaoxia Jia, Yanchun Lu, Jin Lee, Jae Hoon Kim, Kihyun Chen, Wenming Liu, Aijun Liu, Yang Chen, Qi Zhang, Chunyang Suh, Cheolwon Kim, Min Kyoung Zhou, Fan Chng, Wee Joo Kumar, Shaji K. Durie, Brian Hou, Jian Fu, Weijun Du, Juan Leukemia Letter Nature Publishing Group UK 2020-10-20 2021 /pmc/articles/PMC8179848/ /pubmed/33082513 http://dx.doi.org/10.1038/s41375-020-01060-w Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Liu, Jin
Hu, Xiaoxia
Jia, Yanchun
Lu, Jin
Lee, Jae Hoon
Kim, Kihyun
Chen, Wenming
Liu, Aijun
Liu, Yang
Chen, Qi
Zhang, Chunyang
Suh, Cheolwon
Kim, Min Kyoung
Zhou, Fan
Chng, Wee Joo
Kumar, Shaji K.
Durie, Brian
Hou, Jian
Fu, Weijun
Du, Juan
Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN)
title Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN)
title_full Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN)
title_fullStr Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN)
title_full_unstemmed Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN)
title_short Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN)
title_sort clinical features and survival outcomes in igd myeloma: a study by asia myeloma network (amn)
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179848/
https://www.ncbi.nlm.nih.gov/pubmed/33082513
http://dx.doi.org/10.1038/s41375-020-01060-w
work_keys_str_mv AT liujin clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT huxiaoxia clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT jiayanchun clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT lujin clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT leejaehoon clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT kimkihyun clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT chenwenming clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT liuaijun clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT liuyang clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT chenqi clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT zhangchunyang clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT suhcheolwon clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT kimminkyoung clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT zhoufan clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT chngweejoo clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT kumarshajik clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT duriebrian clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT houjian clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT fuweijun clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn
AT dujuan clinicalfeaturesandsurvivaloutcomesinigdmyelomaastudybyasiamyelomanetworkamn